|
CN111995681A
|
|
anti-TIGIT antibody, preparation method and application thereof
|
|
CN110585430A
|
|
Pharmaceutical composition of humanized anti-human IL-17A monoclonal antibody
|
|
CN109929037A
|
|
Conjugate and its application for programmed death ligand
|
|
CN109942712A
|
|
Anti- PD-L1/VEGF bifunctional antibody and application thereof
|
|
CN110606892A
|
|
LAG-3 antibody with high affinity and high biological activity and application thereof
|
|
CN108359011A
|
|
Target the antibody, preparation method and application of interleukin-17 A
|
|
CN104974262A
|
|
Novel recombinant double-function fusion protein, and preparation method and application thereof
|
|
CN103319610A
|
|
Novel recombinant fusion protein, preparation method and use thereof
|
|
WO2015000181A1
|
|
Novel recombinant fusion protein, preparation method therefor and use thereof
|
|
WO2013000234A1
|
|
A novel recomnimant bifunctional fusion protein and its preparation and use
|
